Click for best price
Neuroblastoma Treatment Drugs Market Size, Share 2022
Neuroblastoma (NB) is the most common cancer in childhood and infancy. Most children with neuroblastoma are diagnosed before age 5 and symptoms can range from a painless bump in the abdomen to fevers and limp. Neuroblastoma treatment depends on multiple factors, including the patient's age, whether the tumor has already spread beyond its initial location and the risk of the tumor growing or spreading in the future.
This report contains market size and forecasts of Neuroblastoma Treatment Drugs in global, including the following market information:
Global Neuroblastoma Treatment Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Neuroblastoma Treatment Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Neuroblastoma Treatment Drugs companies in 2021 (%)
The global Neuroblastoma Treatment Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Cyclophosphamide Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Neuroblastoma Treatment Drugs include United Therapeutics, Y-mAbs Therapeutics, EUSA Pharma, ANI Pharmaceuticals, Baxter Healthcare, Ingenus Pharmaceuticals, Pfizer, Hikma Pharmaceuticals and Teva Pharmaceuticals. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Neuroblastoma Treatment Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Neuroblastoma Treatment Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Neuroblastoma Treatment Drugs Market Segment Percentages, by Type, 2021 (%)
Cyclophosphamide
Dinutuximab
Naxitamab
Doxorubicin Hydrochloride
Vincristine Sulfate
Other
Global Neuroblastoma Treatment Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Neuroblastoma Treatment Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Other
Global Neuroblastoma Treatment Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Neuroblastoma Treatment Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Neuroblastoma Treatment Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Neuroblastoma Treatment Drugs revenues share in global market, 2021 (%)
Key companies Neuroblastoma Treatment Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Neuroblastoma Treatment Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
United Therapeutics
Y-mAbs Therapeutics
EUSA Pharma
ANI Pharmaceuticals
Baxter Healthcare
Ingenus Pharmaceuticals
Pfizer
Hikma Pharmaceuticals
Teva Pharmaceuticals
| Report Attributes |
Report Details |
| Report Title |
Neuroblastoma Treatment Drugs Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
73 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Neuroblastoma Treatment Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Neuroblastoma Treatment Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Neuroblastoma Treatment Drugs Overall Market Size
2.1 Global Neuroblastoma Treatment Drugs Market Size: 2021 VS 2028
2.2 Global Neuroblastoma Treatment Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Neuroblastoma Treatment Drugs Sales: 2017-2028
3 Company Landscape
3.1 Top Neuroblastoma Treatment Drugs Players in Global Market
3.2 Top Global Neuroblastoma Treatment Drugs Companies Ranked by Revenue
3.3 Global Neuroblastoma Treatment Drugs Revenue by Companies
3.4 Global Neuroblastoma Treatment Drugs Sales by Companies
3.5 Global Neuroblastoma Treatment Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Neuroblastoma Treatment Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Neuroblastoma Treatment Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Neuroblastoma Treatment Drugs Players in Global Market
3.8.1 List of Global Tier 1 Neuroblastoma Treatment Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Neuroblastoma Treatment Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Neuroblastoma Treatment Drugs Market Size Markets, 2021 & 2028
4.1.2 Cyclophosphamide
4.1.3 Dinutuximab
4.1.4 Naxitamab
4.1.5 Doxorubicin Hydrochloride
4.1.6 Vincristine Sulfate
4.1.7 Other
4.2 By Type - Global Neuroblastoma Treatment Drugs Revenue & Forecasts
4.2.1 By Type - Global Neuroblastoma Treatment Drugs Revenue, 2017-2022
4.2.2 By Type - Global Neuroblastoma Treatment Drugs Revenue, 2023-2028
4.2.3 By Type - Global Neuroblastoma Treatment Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Neuroblastoma Treatment Drugs Sales & Forecasts
4.3.1 By Type - Global Neuroblastoma Treatment Drugs Sales, 2017-2022
4.3.2 By Type - Global Neuroblastoma Treatment Drugs Sales, 2023-2028
4.3.3 By Type - Global Neuroblastoma Treatment Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Neuroblastoma Treatment Drugs Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Neuroblastoma Treatment Drugs Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application - Global Neuroblastoma Treatment Drugs Revenue & Forecasts
5.2.1 By Application - Global Neuroblastoma Treatment Drugs Revenue, 2017-2022
5.2.2 By Application - Global Neuroblastoma Treatment Drugs Revenue, 2023-2028
5.2.3 By Application - Global Neuroblastoma Treatment Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Neuroblastoma Treatment Drugs Sales & Forecasts
5.3.1 By Application - Global Neuroblastoma Treatment Drugs Sales, 2017-2022
5.3.2 By Application - Global Neuroblastoma Treatment Drugs Sales, 2023-2028
5.3.3 By Application - Global Neuroblastoma Treatment Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Neuroblastoma Treatment Drugs Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Neuroblastoma Treatment Drugs Market Size, 2021 & 2028
6.2 By Region - Global Neuroblastoma Treatment Drugs Revenue & Forecasts
6.2.1 By Region - Global Neuroblastoma Treatment Drugs Revenue, 2017-2022
6.2.2 By Region - Global Neuroblastoma Treatment Drugs Revenue, 2023-2028
6.2.3 By Region - Global Neuroblastoma Treatment Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Neuroblastoma Treatment Drugs Sales & Forecasts
6.3.1 By Region - Global Neuroblastoma Treatment Drugs Sales, 2017-2022
6.3.2 By Region - Global Neuroblastoma Treatment Drugs Sales, 2023-2028
6.3.3 By Region - Global Neuroblastoma Treatment Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Neuroblastoma Treatment Drugs Revenue, 2017-2028
6.4.2 By Country - North America Neuroblastoma Treatment Drugs Sales, 2017-2028
6.4.3 US Neuroblastoma Treatment Drugs Market Size, 2017-2028
6.4.4 Canada Neuroblastoma Treatment Drugs Market Size, 2017-2028
6.4.5 Mexico Neuroblastoma Treatment Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Neuroblastoma Treatment Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Neuroblastoma Treatment Drugs Sales, 2017-2028
6.5.3 Germany Neuroblastoma Treatment Drugs Market Size, 2017-2028
6.5.4 France Neuroblastoma Treatment Drugs Market Size, 2017-2028
6.5.5 U.K. Neuroblastoma Treatment Drugs Market Size, 2017-2028
6.5.6 Italy Neuroblastoma Treatment Drugs Market Size, 2017-2028
6.5.7 Russia Neuroblastoma Treatment Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Neuroblastoma Treatment Drugs Market Size, 2017-2028
6.5.9 Benelux Neuroblastoma Treatment Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Neuroblastoma Treatment Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Neuroblastoma Treatment Drugs Sales, 2017-2028
6.6.3 China Neuroblastoma Treatment Drugs Market Size, 2017-2028
6.6.4 Japan Neuroblastoma Treatment Drugs Market Size, 2017-2028
6.6.5 South Korea Neuroblastoma Treatment Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Neuroblastoma Treatment Drugs Market Size, 2017-2028
6.6.7 India Neuroblastoma Treatment Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Neuroblastoma Treatment Drugs Revenue, 2017-2028
6.7.2 By Country - South America Neuroblastoma Treatment Drugs Sales, 2017-2028
6.7.3 Brazil Neuroblastoma Treatment Drugs Market Size, 2017-2028
6.7.4 Argentina Neuroblastoma Treatment Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Neuroblastoma Treatment Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Neuroblastoma Treatment Drugs Sales, 2017-2028
6.8.3 Turkey Neuroblastoma Treatment Drugs Market Size, 2017-2028
6.8.4 Israel Neuroblastoma Treatment Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Neuroblastoma Treatment Drugs Market Size, 2017-2028
6.8.6 UAE Neuroblastoma Treatment Drugs Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 United Therapeutics
7.1.1 United Therapeutics Corporate Summary
7.1.2 United Therapeutics Business Overview
7.1.3 United Therapeutics Neuroblastoma Treatment Drugs Major Product Offerings
7.1.4 United Therapeutics Neuroblastoma Treatment Drugs Sales and Revenue in Global (2017-2022)
7.1.5 United Therapeutics Key News
7.2 Y-mAbs Therapeutics
7.2.1 Y-mAbs Therapeutics Corporate Summary
7.2.2 Y-mAbs Therapeutics Business Overview
7.2.3 Y-mAbs Therapeutics Neuroblastoma Treatment Drugs Major Product Offerings
7.2.4 Y-mAbs Therapeutics Neuroblastoma Treatment Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Y-mAbs Therapeutics Key News
7.3 EUSA Pharma
7.3.1 EUSA Pharma Corporate Summary
7.3.2 EUSA Pharma Business Overview
7.3.3 EUSA Pharma Neuroblastoma Treatment Drugs Major Product Offerings
7.3.4 EUSA Pharma Neuroblastoma Treatment Drugs Sales and Revenue in Global (2017-2022)
7.3.5 EUSA Pharma Key News
7.4 ANI Pharmaceuticals
7.4.1 ANI Pharmaceuticals Corporate Summary
7.4.2 ANI Pharmaceuticals Business Overview
7.4.3 ANI Pharmaceuticals Neuroblastoma Treatment Drugs Major Product Offerings
7.4.4 ANI Pharmaceuticals Neuroblastoma Treatment Drugs Sales and Revenue in Global (2017-2022)
7.4.5 ANI Pharmaceuticals Key News
7.5 Baxter Healthcare
7.5.1 Baxter Healthcare Corporate Summary
7.5.2 Baxter Healthcare Business Overview
7.5.3 Baxter Healthcare Neuroblastoma Treatment Drugs Major Product Offerings
7.5.4 Baxter Healthcare Neuroblastoma Treatment Drugs Sales and Revenue in Global (2017-2022)
7.5.5 Baxter Healthcare Key News
7.6 Ingenus Pharmaceuticals
7.6.1 Ingenus Pharmaceuticals Corporate Summary
7.6.2 Ingenus Pharmaceuticals Business Overview
7.6.3 Ingenus Pharmaceuticals Neuroblastoma Treatment Drugs Major Product Offerings
7.6.4 Ingenus Pharmaceuticals Neuroblastoma Treatment Drugs Sales and Revenue in Global (2017-2022)
7.6.5 Ingenus Pharmaceuticals Key News
7.7 Pfizer
7.7.1 Pfizer Corporate Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Neuroblastoma Treatment Drugs Major Product Offerings
7.7.4 Pfizer Neuroblastoma Treatment Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Pfizer Key News
7.8 Hikma Pharmaceuticals
7.8.1 Hikma Pharmaceuticals Corporate Summary
7.8.2 Hikma Pharmaceuticals Business Overview
7.8.3 Hikma Pharmaceuticals Neuroblastoma Treatment Drugs Major Product Offerings
7.8.4 Hikma Pharmaceuticals Neuroblastoma Treatment Drugs Sales and Revenue in Global (2017-2022)
7.8.5 Hikma Pharmaceuticals Key News
7.9 Teva Pharmaceuticals
7.9.1 Teva Pharmaceuticals Corporate Summary
7.9.2 Teva Pharmaceuticals Business Overview
7.9.3 Teva Pharmaceuticals Neuroblastoma Treatment Drugs Major Product Offerings
7.9.4 Teva Pharmaceuticals Neuroblastoma Treatment Drugs Sales and Revenue in Global (2017-2022)
7.9.5 Teva Pharmaceuticals Key News
8 Global Neuroblastoma Treatment Drugs Production Capacity, Analysis
8.1 Global Neuroblastoma Treatment Drugs Production Capacity, 2017-2028
8.2 Neuroblastoma Treatment Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Neuroblastoma Treatment Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Neuroblastoma Treatment Drugs Supply Chain Analysis
10.1 Neuroblastoma Treatment Drugs Industry Value Chain
10.2 Neuroblastoma Treatment Drugs Upstream Market
10.3 Neuroblastoma Treatment Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Neuroblastoma Treatment Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Neuroblastoma Treatment Drugs in Global Market
Table 2. Top Neuroblastoma Treatment Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Neuroblastoma Treatment Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Neuroblastoma Treatment Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Neuroblastoma Treatment Drugs Sales by Companies, (K Units), 2017-2022
Table 6. Global Neuroblastoma Treatment Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Neuroblastoma Treatment Drugs Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Neuroblastoma Treatment Drugs Product Type
Table 9. List of Global Tier 1 Neuroblastoma Treatment Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Neuroblastoma Treatment Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Neuroblastoma Treatment Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Neuroblastoma Treatment Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Neuroblastoma Treatment Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Neuroblastoma Treatment Drugs Sales (K Units), 2017-2022
Table 15. By Type - Global Neuroblastoma Treatment Drugs Sales (K Units), 2023-2028
Table 16. By Application ? Global Neuroblastoma Treatment Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Neuroblastoma Treatment Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Neuroblastoma Treatment Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Neuroblastoma Treatment Drugs Sales (K Units), 2017-2022
Table 20. By Application - Global Neuroblastoma Treatment Drugs Sales (K Units), 2023-2028
Table 21. By Region ? Global Neuroblastoma Treatment Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Neuroblastoma Treatment Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Neuroblastoma Treatment Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Neuroblastoma Treatment Drugs Sales (K Units), 2017-2022
Table 25. By Region - Global Neuroblastoma Treatment Drugs Sales (K Units), 2023-2028
Table 26. By Country - North America Neuroblastoma Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Neuroblastoma Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Neuroblastoma Treatment Drugs Sales, (K Units), 2017-2022
Table 29. By Country - North America Neuroblastoma Treatment Drugs Sales, (K Units), 2023-2028
Table 30. By Country - Europe Neuroblastoma Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Neuroblastoma Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Neuroblastoma Treatment Drugs Sales, (K Units), 2017-2022
Table 33. By Country - Europe Neuroblastoma Treatment Drugs Sales, (K Units), 2023-2028
Table 34. By Region - Asia Neuroblastoma Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Neuroblastoma Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Neuroblastoma Treatment Drugs Sales, (K Units), 2017-2022
Table 37. By Region - Asia Neuroblastoma Treatment Drugs Sales, (K Units), 2023-2028
Table 38. By Country - South America Neuroblastoma Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Neuroblastoma Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Neuroblastoma Treatment Drugs Sales, (K Units), 2017-2022
Table 41. By Country - South America Neuroblastoma Treatment Drugs Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Neuroblastoma Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Neuroblastoma Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Neuroblastoma Treatment Drugs Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Neuroblastoma Treatment Drugs Sales, (K Units), 2023-2028
Table 46. United Therapeutics Corporate Summary
Table 47. United Therapeutics Neuroblastoma Treatment Drugs Product Offerings
Table 48. United Therapeutics Neuroblastoma Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Y-mAbs Therapeutics Corporate Summary
Table 50. Y-mAbs Therapeutics Neuroblastoma Treatment Drugs Product Offerings
Table 51. Y-mAbs Therapeutics Neuroblastoma Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. EUSA Pharma Corporate Summary
Table 53. EUSA Pharma Neuroblastoma Treatment Drugs Product Offerings
Table 54. EUSA Pharma Neuroblastoma Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. ANI Pharmaceuticals Corporate Summary
Table 56. ANI Pharmaceuticals Neuroblastoma Treatment Drugs Product Offerings
Table 57. ANI Pharmaceuticals Neuroblastoma Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Baxter Healthcare Corporate Summary
Table 59. Baxter Healthcare Neuroblastoma Treatment Drugs Product Offerings
Table 60. Baxter Healthcare Neuroblastoma Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Ingenus Pharmaceuticals Corporate Summary
Table 62. Ingenus Pharmaceuticals Neuroblastoma Treatment Drugs Product Offerings
Table 63. Ingenus Pharmaceuticals Neuroblastoma Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Pfizer Corporate Summary
Table 65. Pfizer Neuroblastoma Treatment Drugs Product Offerings
Table 66. Pfizer Neuroblastoma Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Hikma Pharmaceuticals Corporate Summary
Table 68. Hikma Pharmaceuticals Neuroblastoma Treatment Drugs Product Offerings
Table 69. Hikma Pharmaceuticals Neuroblastoma Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Teva Pharmaceuticals Corporate Summary
Table 71. Teva Pharmaceuticals Neuroblastoma Treatment Drugs Product Offerings
Table 72. Teva Pharmaceuticals Neuroblastoma Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Neuroblastoma Treatment Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 74. Global Neuroblastoma Treatment Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 75. Global Neuroblastoma Treatment Drugs Production by Region, 2017-2022 (K Units)
Table 76. Global Neuroblastoma Treatment Drugs Production by Region, 2023-2028 (K Units)
Table 77. Neuroblastoma Treatment Drugs Market Opportunities & Trends in Global Market
Table 78. Neuroblastoma Treatment Drugs Market Drivers in Global Market
Table 79. Neuroblastoma Treatment Drugs Market Restraints in Global Market
Table 80. Neuroblastoma Treatment Drugs Raw Materials
Table 81. Neuroblastoma Treatment Drugs Raw Materials Suppliers in Global Market
Table 82. Typical Neuroblastoma Treatment Drugs Downstream
Table 83. Neuroblastoma Treatment Drugs Downstream Clients in Global Market
Table 84. Neuroblastoma Treatment Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Neuroblastoma Treatment Drugs Segment by Type
Figure 2. Neuroblastoma Treatment Drugs Segment by Application
Figure 3. Global Neuroblastoma Treatment Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Neuroblastoma Treatment Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Neuroblastoma Treatment Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Neuroblastoma Treatment Drugs Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Neuroblastoma Treatment Drugs Revenue in 2021
Figure 9. By Type - Global Neuroblastoma Treatment Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Neuroblastoma Treatment Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Neuroblastoma Treatment Drugs Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Neuroblastoma Treatment Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Neuroblastoma Treatment Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Neuroblastoma Treatment Drugs Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Neuroblastoma Treatment Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Neuroblastoma Treatment Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Neuroblastoma Treatment Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Neuroblastoma Treatment Drugs Sales Market Share, 2017-2028
Figure 19. US Neuroblastoma Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Neuroblastoma Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Neuroblastoma Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Neuroblastoma Treatment Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Neuroblastoma Treatment Drugs Sales Market Share, 2017-2028
Figure 24. Germany Neuroblastoma Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Neuroblastoma Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Neuroblastoma Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Neuroblastoma Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Neuroblastoma Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Neuroblastoma Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Neuroblastoma Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Neuroblastoma Treatment Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Neuroblastoma Treatment Drugs Sales Market Share, 2017-2028
Figure 33. China Neuroblastoma Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Neuroblastoma Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Neuroblastoma Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Neuroblastoma Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Neuroblastoma Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Neuroblastoma Treatment Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Neuroblastoma Treatment Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Neuroblastoma Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Neuroblastoma Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Neuroblastoma Treatment Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Neuroblastoma Treatment Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Neuroblastoma Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Neuroblastoma Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Neuroblastoma Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Neuroblastoma Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Neuroblastoma Treatment Drugs Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Neuroblastoma Treatment Drugs by Region, 2021 VS 2028
Figure 50. Neuroblastoma Treatment Drugs Industry Value Chain
Figure 51. Marketing Channels
